8- O -( E - p -methoxycinnamoyl)harpagide Inhibits Influenza A Virus Infection by Suppressing Intracellular Calcium

• Published in: Molecules (Basel, Switzerland) Vol. 26; no. 4; p. 1029
• Main Authors: Kwon, Eun-Bin, Yang, Hye-Jin, Kim, Young-Soo, Li, Wei, Choi, Jang-Gi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 15.02.2021; MDPI AG
• Subjects: 8-O-(E-p-methoxycinnamoyl)harpagide; A549 Cells; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Calcium - metabolism; Communication; Humans; influenza A virus; Influenza A virus - drug effects; Influenza, Human - drug therapy; Influenza, Human - virology; intracellular calcium; Intracellular Space - metabolism; Ion Channels - metabolism; Iridoid Glycosides - chemistry; Iridoid Glycosides - pharmacology; Iridoid Glycosides - therapeutic use; M2 ion channel; Mitochondria - drug effects; Mitochondria - pathology; Molecular Docking Simulation; Pyrans - chemistry; Pyrans - pharmacology; Pyrans - therapeutic use; reactive oxygen species; Viral Matrix Proteins; intracellular calcium; 8-O-(E-p-methoxycinnamoyl)harpagide; reactive oxygen species; M2 ion channel; influenza A virus
• DOI: 10.3390/molecules26041029
• ISSN: 1420-3049

Calcium (Ca ) dependent signaling circuit plays a critical role in influenza A virus (IAV) infection. The 8- -( - -methoxycinnamoyl)harpagide (MCH) exhibits pharmacological activities that exert neuroprotective, hepatoprotective, anti-inflammatory and other biological effects. However, not have reports of antiviral effects. To investigate the antiviral activity of MCH on IAV-infected human lung cells mediated by calcium regulation. We examined the inhibitory effect of MCH on IAV infections and measured the level of viral proteins upon MCH treatment using Western blotting. We also performed molecular docking simulation with MCH and IAV M2 protein. Finally, we analyzed MCH's suppression of intracellular calcium and ROS (reactive oxygen species) in IAV-infected human lung cells using a flow cytometer. The results shown that MCH inhibited the infection of IAV and increased the survival of the infected human lung cells. The levels of IAV protein M1, M2, NS1 and PA were inhibited in MCH-treated human lung cells compared to that in infected and untreated cells. Also, docking simulation suggest that MCH interacted with M2 on its hydrophobic wall (L40 and I42) and polar amino acids (D44 and R45), which formed intermolecular contacts and were a crucial part of the channel gate along with W41. Lastly, MCH inhibited IAV infection by reducing intracellular calcium and mitochondrial Ca /ROS levels in infected human lung cells. Taken together, these data suggest that MCH inhibits IAV infection and increases the survival of infected human lung cells by suppressing calcium levels. These results indicate that MCH is useful for developing IAV treatments.